Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Minimally invasive third ventriculostomy with stereotactic internal shunt placement for the treatment of tumor-associated noncommunicating hydrocephalus

View through CrossRef
Abstract Background Intracranial tumors can cause obstructive hydrocephalus (OH). Most often, symptomatic treatment is pursued through ventriculoperitoneal shunt (VS) or endoscopic third ventriculostomy (ETV). In this study, we propose stereotactic third ventriculostomy with internal shunt placement (sTVIP) as an alternative treatment option and assess its safety and efficacy. Methods In this single-center, retrospective analysis, clinical symptoms, procedure-related complications, and revision-free survival of all patients with OH due to tumor formations treated by sTVIP between January 2010 and December 2021 were evaluated. Results Clinical records of thirty-eight patients (11 female, 27 male) with a mean age of 40 years (range 5–88) were analyzed. OH was predominantly (in 92% of patients) caused by primary brain tumors (with exception of 3 cases with metastases). Following sTVIP, 74.2% of patients experienced symptomatic improvement. Preoperative headache was a significant predictor of postoperative symptomatic improvement (OR 26.25; 95% CI 4.1–521.1; p = 0.0036). Asymptomatic hemorrhage was detected along the stereotactic trajectory in 2 cases (5.3%). One patient required local revision due to CSF fistula (2.6%); another patient had to undergo secondary surgery to connect the catheter to a valve/abdominal catheter due to CSF malabsorption. However, in the remaining 37 patients, shunt independence was maintained during a median follow-up period of 12 months (IQR 3–32 months). No surgery-related mortality was observed. Conclusions sTVIP led to a significant symptom control and was associated with low operative morbidity, along with a high rate of ventriculoperitoneal shunt independency during the follow-up period. Therefore, sTVIP constitutes a highly effective and minimally invasive treatment option for tumor-associated obstructive hydrocephalus, even in cases with a narrow prepontine interval.
Title: Minimally invasive third ventriculostomy with stereotactic internal shunt placement for the treatment of tumor-associated noncommunicating hydrocephalus
Description:
Abstract Background Intracranial tumors can cause obstructive hydrocephalus (OH).
Most often, symptomatic treatment is pursued through ventriculoperitoneal shunt (VS) or endoscopic third ventriculostomy (ETV).
In this study, we propose stereotactic third ventriculostomy with internal shunt placement (sTVIP) as an alternative treatment option and assess its safety and efficacy.
Methods In this single-center, retrospective analysis, clinical symptoms, procedure-related complications, and revision-free survival of all patients with OH due to tumor formations treated by sTVIP between January 2010 and December 2021 were evaluated.
Results Clinical records of thirty-eight patients (11 female, 27 male) with a mean age of 40 years (range 5–88) were analyzed.
OH was predominantly (in 92% of patients) caused by primary brain tumors (with exception of 3 cases with metastases).
Following sTVIP, 74.
2% of patients experienced symptomatic improvement.
Preoperative headache was a significant predictor of postoperative symptomatic improvement (OR 26.
25; 95% CI 4.
1–521.
1; p = 0.
0036).
Asymptomatic hemorrhage was detected along the stereotactic trajectory in 2 cases (5.
3%).
One patient required local revision due to CSF fistula (2.
6%); another patient had to undergo secondary surgery to connect the catheter to a valve/abdominal catheter due to CSF malabsorption.
However, in the remaining 37 patients, shunt independence was maintained during a median follow-up period of 12 months (IQR 3–32 months).
No surgery-related mortality was observed.
Conclusions sTVIP led to a significant symptom control and was associated with low operative morbidity, along with a high rate of ventriculoperitoneal shunt independency during the follow-up period.
Therefore, sTVIP constitutes a highly effective and minimally invasive treatment option for tumor-associated obstructive hydrocephalus, even in cases with a narrow prepontine interval.

Related Results

Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract Introduction  Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Dandy-Walker syndrome with hydrocephalus undergoing VPS or CPS?——A single-centre retrospective study
Dandy-Walker syndrome with hydrocephalus undergoing VPS or CPS?——A single-centre retrospective study
Abstract Objective: Dandy-Walker syndrome (DWS) is often associated with hydrocephalus, yet the choice between lateral ventriculoperitoneal shunt (VPS) or posterior cranial...
LAPAROSCOPIC ASSISTED TREATMENT OF HYDROCEPHALUS IN ADULTS: OUR OWN MODIFICATION
LAPAROSCOPIC ASSISTED TREATMENT OF HYDROCEPHALUS IN ADULTS: OUR OWN MODIFICATION
Introduction: Laparoscopy has been used as an aid in the placement of abdominal ventriculoperitoneal (VP) shunts since 1993. Laparoscopic procedures are safe and allow direct visua...
Thallium SPECT-Based Stereotactic Targeting for Brain Tumor Biopsies
Thallium SPECT-Based Stereotactic Targeting for Brain Tumor Biopsies
MR or CT images acquired under stereotactic conditions are often used to plan and guide brain tumor biopsies. The objective of this study was to design and test a methodology to in...

Back to Top